TMCnet News

Global Biotechnology Reagents Market Worth $94.6 Billion by 2022 - Driven By R&D Investments & Growth in Biopharmaceuticals - Research and Markets
[October 21, 2016]

Global Biotechnology Reagents Market Worth $94.6 Billion by 2022 - Driven By R&D Investments & Growth in Biopharmaceuticals - Research and Markets


Research and Markets has announced the addition of the "Global Biotechnology Reagent Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022" report to their offering.

The global biotechnology reagents market is expected to reach above $94.6 billion in 2022 and is anticipated to grow at a CAGR of 9.0% between periods 2016 and 2022.

Growing R&D investments on biotechnology sector, growing number of biotechnology firms, growth in biopharmaceuticals, new upcoming technology and rising protein profiling are some of the drivers of the global biotechnology reagents market. According to research journal Nature, the biotechnology research & development investment has jumped to $40.1billion in 2015 up 16% from $34.5billion in 2014.

Biopharmaceuticals is one of those promising sectors aligning biotechnology. Biopharmaceuticals manufacture healthcare drugs using biotechnology process. Biopharmaceutical products involve proteins like antibodies, nucleic acids like DNA, RNA, olignonucleotides, which are later used in therapeutic and in vivo diagnostic purposes. Recombinan Human insulin is one of the first and common biopharmaceuticals product manufactured today. Oncology, anti-viral and auto immune disorders are poised for greatest growth in biopharmaceuticals in coming years. It is estimated that speciality and biologic drugs will make up half of healthcare industry by 2022. Opportunities in biotechnology reagent market for the forecasted period are stem cells research and environmental biotechnology research.



North America is the largest market for biotechnology reagents followed by Europe and Asia Pacific. Innovation of new products, government policies & initiatives, positive regulatory environment, sound healthcare sector, and large investments in biotechnology research are the factors driving the North American market. US is anticipated as the fastest growing market for biotechnology reagents for the forecasted period, following the completion of human genome project successfully and rising demand of reagents for molecular biology.

Companies Mentioned:


  • Abbott Laboratories
  • Agilent Technologies (News - Alert) Inc.
  • Beckman Coulter Inc.
  • Becton, Dickinson And Company (Bd)
  • Biomerieux
  • Bio-Rad Laboratories Inc.
  • Ge Healthcare
  • Hoefer Inc.
  • Life Technologies Corporation
  • Lonza Group Ltd.
  • Meridian Biosciences Inc.
  • Merck Millipore
  • Perkinelmer
  • Sigma Aldrich Corporation
  • Quality Biological Inc.

Key Topics Covered:

1. Introduction

2. Market Overview

3. Market Determinants

4. Market Segmentation

5. Geographic Analysis

6. Company Profile

For more information about this report visit http://www.researchandmarkets.com/research/24fx77/global


[ Back To TMCnet.com's Homepage ]